Effect of Q10 Coenzyme in Improving Cardiac Functio
Phase 2
- Conditions
- Duchenne Moscular Dystrophy.Muscular dystrophy
- Registration Number
- IRCT2015070223018N1
- Lead Sponsor
- Deputy of Research and Education at Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
The patients with Duchenne muscular dystrophy aged between 6 -10 years; parental consent to enter the study; without cardiac disease in the intervention group; without structural cardiac disease in the control group; untreated with herbal, vitamin and enzyme medications.
Exclusion criteria: The patients without Duchenne muscular dystrophy; Patients age less than 6 years or above 10 years; parental lack of consent for entering the study; Patients with cardiac disease in the intervention group; Patients with structural cardiac disease in the control group; inappropriate echocardiography; Patients treated with of herbal s, vitamin and enzyme medications.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method eft ventricular filling index. Timepoint: 3 and 6 months after using the medication. Method of measurement: Tissue doppler.
- Secondary Outcome Measures
Name Time Method E Declaretion. Timepoint: 3 and 6 months after using the medication. Method of measurement: Eco.